These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2214584)

  • 1. [Evaluation of the adequacy of heparin administration during hemosorption].
    Iunovidova LI; Lekhtman AM; Levantovskaia OM
    Khirurgiia (Mosk); 1990 Jun; (6):85-8. PubMed ID: 2214584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the correction of the blood aggregate condition during extracorporeal hemosorption in hematologic patients].
    Katsadze IuL; Ganapiev AA
    Ter Arkh; 1985; 57(10):80-5. PubMed ID: 4082003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled heparinization during hemosorption].
    Marochkov AV; Iurchenko AA; Kravtsov NN
    Vestn Khir Im I I Grek; 1985 Mar; 134(3):101-3. PubMed ID: 4002508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative hemosorption in patients with obstructive jaundice. Value of the method, complications and their prevention].
    Riabtsev VG; Myslovatyĭ BS; Gorbovitskiĭ EB; Bol'shakova TD; Aleksandrovskaia TN
    Sov Med; 1986; (3):98-100. PubMed ID: 3715592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of adequate heparinization during artificial circulation in the framework of prolonged intraoperative administration of high doses of aprotinin].
    Dement'eva II; Charnaia MA; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1994; (3):32-5. PubMed ID: 7521582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correction of intraoperative disorders of hemostasis during aortocoronary bypass in patients with chronic ischemic heart disease].
    Kurochkin VM; Iagudina DN; Soboleva ER; Berdichevskiĭ MS
    Anesteziol Reanimatol; 1988; (2):21-4. PubMed ID: 3261556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative determination of heparin in the blood during hemosorption].
    Efimov VS
    Anesteziol Reanimatol; 1982; (6):46-9. PubMed ID: 7158844
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation potential in patients with mechanical jaundice during hemosorption].
    Lekhtman AM; Iunovidova LI; Levantovskaia OM
    Sov Med; 1990; (2):65-7. PubMed ID: 2356532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efferent methods in the complex treatment of myasthenia gravis].
    Sazonov AM; Kalinin AP; Kil'diushevskiĭ AV; Lekhtman AM; Agafonov BV
    Sov Med; 1989; (1):17-20. PubMed ID: 2718018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Routine heparinization and activated clotting time (ACT) in patients operated on under extracorporeal circulation].
    Kalawski R; Krzyś T; Leciej M
    Wiad Lek; 1982 Oct; 35(18):1119-24. PubMed ID: 7179984
    [No Abstract]   [Full Text] [Related]  

  • 15. Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice.
    Brister SJ; Ofosu FA; Heigenhauser GJ; Gianese F; Buchanan MR
    Thromb Haemost; 1994 Apr; 71(4):468-73. PubMed ID: 8052965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrin-stabilizing factor and its significance in the surgical treatment of patients with obstructive jaundice].
    Myslovatyĭ BS; Gorbovitskiĭ EB; Deputovich SA; Dzheĭranov FD
    Vestn Khir Im I I Grek; 1989 Mar; 142(3):79-81. PubMed ID: 2750013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemosorption during and after surgery in mechanical jaundice].
    Sazonov AM; Ender LA; Lobakov AI; Lekhtman AM; Agureev AI
    Sov Med; 1981; (6):53-7. PubMed ID: 7280797
    [No Abstract]   [Full Text] [Related]  

  • 19. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
    Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration of dalteparin in reconstructive vascular surgery].
    Pokrovskiĭ AV; Gontarenko VN; Titova MI
    Angiol Sosud Khir; 2011; 17(2):17-22. PubMed ID: 21983457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.